Behenic Acid

What is Behenic Acid?

Behenic Acid, also known by the chemical name docosanoic acid, is a saturated fatty acid with a long carbon chain of 22 atoms. It belongs to the group of long-chain saturated fatty acids and occurs naturally in various plant oils and animal fats. Particularly high concentrations are found, for example, in peanut oil, rapeseed oil, and moringa oil. As a saturated fatty acid, Behenic Acid is solid at room temperature and exhibits high chemical stability. In nature, it often serves as a structural component in cell membranes and as an energy source. Industrially, it is used, among other things, as a component of waxes, lubricants, cosmetics, and pharmaceutical products. Although saturated fatty acids as a whole are often viewed critically, a more nuanced picture emerges for long-chain representatives such as Behenic Acid. Its biological behavior differs in some cases considerably from that of shorter-chain saturated fatty acids – both with regard to metabolism and to possible health effects.

What benefits does Behenic Acid offer for health?

Research on Behenic Acid has been very limited so far, but there are initial indications of interesting properties – particularly in connection with skin care and lipid metabolism. In general, however, it must be mentioned that more research is necessary in order to be able to make definitive statements about the effects of Behenic Acid. Here is a selection of the research findings to date. However, these should be viewed critically and are not readily transferable:

  • Function as a transporter: Docosanoic acid nanoparticles have proven to be promising carriers for lipid-soluble drugs and could improve their delivery into cells for the treatment of intracellular bacterial infections (1).
  • Cardiovascular effect: One study found a linear association between docosanoic acid levels and a reduced risk of cardiovascular and all-cause mortality in CKD patients (2,3).
  • Gene silencing: The conjugation of docosanoic acid with siRNA enables efficient and sustained gene silencing in muscle tissue after systemic injection (4).
  • Influence on blood sugar levels: Studies suggest that Behenic Acid could lower the incidence of type 2 diabetes, as it significantly influences the function of the β-cells and insulin sensitivity (3,5,6).
  • Antibacterial effect: Investigations indicate that Behenic Acid exhibits a strong antibacterial effect against several target groups (3,7).
  • Antioxidant and anti-inflammatory effect: Investigations point to an antioxidant and anti-inflammatory effect (3,6).

How does Behenic Acid work in the body?

Behenic Acid is metabolized less efficiently in the body than short-chain fatty acids. Due to its length, it is only converted into energy to a limited extent and tends to be incorporated into cell membranes or excreted. While the antibacterial effect appears to depend on the inhibition of catalase-peroxidase, adenylosuccinate synthetase, and pyridoxine 5′-phosphate synthase, the antidiabetic effect is based on a change in the beta cells (3).

Are there any risks or side effects?

  • Limited absorption: Due to its long chain, Behenic Acid is absorbed less well in the human digestive system than short-chain fatty acids – health risks are therefore unlikely at normal amounts.
  • No known toxic effects at usual dosages: In the usual amounts from foods or cosmetics, Behenic Acid is well tolerated.
  • Consider saturated fats in the overall context: As with all saturated fatty acids: the effect on health depends on the overall fat pattern of the diet – a balanced ratio with unsaturated fatty acids is recommended.

Conclusion

Behenic Acid is a long-chain, saturated fatty acid with stable physicochemical properties and versatile significance in cosmetics, nutrition, and biochemistry. In terms of health, no acute risks are known, although its role in metabolism has not yet been fully researched. Its effects have likewise not yet been sufficiently researched to allow definitive statements to be made.

Sources:

  1. Meng, K., Chen, D., Yang, F., Zhang, A., Tao, Y., Qu, W., Pan, Y., Hao, H., & Xie, S. (2020). Intracellular delivery, accumulation, and discrepancy in antibacterial activity of four enrofloxacin-loaded fatty acid solid lipid nanoparticles. Colloids and Surfaces B: Biointerfaces, 194, 111196. https://doi.org/10.1016/j.colsurfb.2020.111196
  2. Meng, X., Yang, Q., Li, Z., Zhou, P., Li, W., Liang, Q., Wu, T., Gao, W., Yu, H., Deng, G., Zhang, J., Xiao, X., & Meng, X. (2025, March 14). The association between docosanoic acid and the risks of occurrence and mortality of chronic kidney disease [Preprint]. medRxiv. https://doi.org/10.1101/2025.03.14.25322644
  3. Koriem, K. M. M., & El-Masry, M. S. R. (2024). Behenic acid protects the testosterone cycle and prevents the sperm apoptosis and protein loss in phthalate exposure by inhibiting oxidative stress and stimulating ATPase activity. Toxicology reports, 13, 101845. https://doi.org/10.1016/j.toxrep.2024.101845
  4. Biscans, A., Caiazzi, J., McHugh, N., Hariharan, V., Muhuri, M., & Khvorova, A. (2021). Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles. Molecular therapy : the journal of the American Society of Gene Therapy, 29(4), 1382–1394. https://doi.org/10.1016/j.ymthe.2020.12.023
  5. Lai K.Z.H., Semnani-Azad Z., Boucher B.A., Retnakaran R., Harris S.B., Malik V., et al. Association of serum very-long-chain saturated fatty acids with changes in insulin sensitivity and β-cell function: the prospective metabolism and islet cell evaluation (PROMISE) cohort. Diabetes. 2023;72(11):1664–1670. doi: 10.2337/db22-1050.
  6. Liu, K., Gu, Y., Pan, X., Chen, S., Cheng, J., Zhang, L., & Cao, M. (2024). Behenic acid alleviates inflammation and insulin resistance in gestational diabetes mellitus by regulating TLR4/NF-κB signaling pathway. iScience, 27(10), 111019. https://doi.org/10.1016/j.isci.2024.111019
  7. Ravi L., Kumar K.A., G R S.K., Mathew J., S H., Panda M., S S., Paul A., Ts C., Anil A., J K.M., Mukherjee T., Bhattacharjee S., Raveendran Nair M., V S., V M., Jain P. Behenic Acid as a multi-target inhibiting antibacterial phytochemical against Vibrio parahaemolyticus and Aeromonas hydrophila for effective management of aquaculture infections: an in-silico, in-vitro & in-vivo experimentation. J. Biomol. Struct. Dyn. 2024:1–16. doi: 10.1080/07391102.2024.2317988.